Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oral Caffeine on Fatigue in Multiple Sclerosis Patients
IRCT20241129063892N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine in multiple sclerosis (MS), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Change in fatigue severity. Started Dec 2024; status: completed.
02
Drugs
caffeine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20241129063892N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241129063892N1.